Literature DB >> 12594656

First case of Mycobacterium ulcerans disease (Buruli ulcer) following a human bite.

Martine Debacker1, Claude Zinsou, Julia Aguiar, Wayne M Meyers, Françoise Portaels.   

Abstract

Mycobacterium ulcerans disease (MUD) is rapidly reemerging in many countries, especially in West African countries. Antecedent trauma has often been related to the lesions that characterize this frequently crippling disease. We report here the first case of MUD that followed a human bite at the site where the lesion later occurred.

Entities:  

Mesh：

Year:  2003        PMID： 12594656     DOI： 10.1086/367660

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  18 in total

1.  A genotypic approach for detection, identification, and characterization of drug resistance in Mycobacterium ulcerans in clinical samples and isolates from Ghana.

Authors:  Marcus Beissner; Nana-Yaa Awua-Boateng; William Thompson; Willemien A Nienhuis; Erasmus Klutse; Pius Agbenorku; Joerg Nitschke; Karl-Heinz Herbinger; Vera Siegmund; Erna Fleischmann; Ohene Adjei; Bernhard Fleischer; Tjip S van der Werf; Thomas Loscher; Gisela Bretzel
Journal:  Am J Trop Med Hyg       Date:  2010-11       Impact factor: 2.345

Review 2.  Pathogenesis of skin ulcers: lessons from the Mycobacterium ulcerans and Leishmania spp. pathogens.

Authors:  Laure Guenin-Macé; Reid Oldenburg; Fabrice Chrétien; Caroline Demangel
Journal:  Cell Mol Life Sci       Date:  2014-01-21       Impact factor: 9.261

Review 3.  Buruli Ulcer, a Prototype for Ecosystem-Related Infection, Caused by Mycobacterium ulcerans.

Authors:  Dezemon Zingue; Amar Bouam; Roger B D Tian; Michel Drancourt
Journal:  Clin Microbiol Rev       Date:  2017-12-13       Impact factor: 26.132

4.  Under treated necrotizing fasciitis masquerading as ulcerated edematous Mycobacterium ulcerans infection (Buruli ulcer).

Authors:  Mavinga D Phanzu; Aombe E Bafende; Bofunga B D Imposo; Wayne M Meyers; Françoise Portaels
Journal:  Am J Trop Med Hyg       Date:  2010-03       Impact factor: 2.345

5.  Impact of Dose, Duration, and Immune Status on Efficacy of Ultrashort Telacebec Regimens in Mouse Models of Buruli Ulcer.

Authors:  Oliver Komm; Deepak V Almeida; Paul J Converse; Till F Omansen; Eric L Nuermberger
Journal:  Antimicrob Agents Chemother       Date:  2021-08-30       Impact factor: 5.191

Review 6.  Buruli ulcer disease: prospects for a vaccine.

Authors:  Kris Huygen; Ohene Adjei; Dissou Affolabi; Gisela Bretzel; Caroline Demangel; Bernhard Fleischer; Roch Christian Johnson; Jorge Pedrosa; Delphin M Phanzu; Richard O Phillips; Gerd Pluschke; Vera Siegmund; Mahavir Singh; Tjip S van der Werf; Mark Wansbrough-Jones; Françoise Portaels
Journal:  Med Microbiol Immunol       Date:  2009-02-07       Impact factor: 3.402

Review 7.  Ecology and transmission of Buruli ulcer disease: a systematic review.

Authors:  Richard W Merritt; Edward D Walker; Pamela L C Small; John R Wallace; Paul D R Johnson; M Eric Benbow; Daniel A Boakye
Journal:  PLoS Negl Trop Dis       Date:  2010-12-14

8.  Detection of Mycobacterium ulcerans in the environment predicts prevalence of Buruli ulcer in Benin.

Authors:  Heather R Williamson; Mark E Benbow; Lindsay P Campbell; Christian R Johnson; Ghislain Sopoh; Yves Barogui; Richard W Merritt; Pamela L C Small
Journal:  PLoS Negl Trop Dis       Date:  2012-01-31

9.  Protection against Mycobacterium ulcerans lesion development by exposure to aquatic insect saliva.

Authors:  Laurent Marsollier; Estelle Deniaux; Priscille Brodin; Agnès Marot; Christelle Mbondji Wondje; Jean-Paul Saint-André; Annick Chauty; Christian Johnson; Fredj Tekaia; Edouard Yeramian; Pierre Legras; Bernard Carbonnelle; Gilles Reysset; Sara Eyangoh; Geneviève Milon; Stewart T Cole; Jacques Aubry
Journal:  PLoS Med       Date:  2007-02       Impact factor: 11.069

10.  Risk factors for Buruli ulcer, Benin.

Authors:  Martine Debacker; Frangoise Portaels; Julia Aguiar; Christian Steunou; Claude Zinsou; Wayne Meyers; Michèle Dramaix
Journal:  Emerg Infect Dis       Date:  2006-09       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.